This webinar has now concluded

AACR 2024: DDR Related Abstracts

AACR 2024 has demonstrated a flourish of new and exciting data within the DDR space. But with exponential growth comes a more intricate challenge – tracking and analyzing the impact on your development pipelines.

In our latest webinar, we cut through the noise and took a dive into the latest developments across the DDR landscape, providing a comprehensive analysis of 160+ new abstracts, including 30 new drugs, released from AACR this year.

AACR 2024: DDR Abstract Highlights Webinar

Our expert panel meticulously reviewed the preclinical and clinical data presented and offered valuable insights into emerging trends and promising future milestones as the landscape continues to gain momentum. Watch the recording now.

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search